Dr. Anne Wagner and Dr. Michael Mithoefer discuss therapeutic potential of MDMA for couples, sharing insights from their MDMA-assisted couples therapy trials and ongoing research with Dr. Chandra Khalifian and
Chandra Khalifian, Leslie Morland, Kayla Knopp
MAPS completes Phase 3 study for MDMA-AT in PTSD treatment, marking historic milestone in psychedelic drug research. Safety and efficacy of MDMA-assisted therapy still under investigation.
Keren Tzarfaty, Michael Mithoefer, Julie Holland
Therapists and clinicians must collaborate to integrate psychedelic therapy into the behavioral health system, engaging professional organizations, providers, payers, and policymakers. Key steps for integration and clinician involvement will be
David Esselman, Sarah Abedi
Panel explores challenges of managing expectations and risks in psychedelic-assisted therapy amid growing media coverage. Participants, patients, and practitioners often lack information on risks.
David B Yaden, Xiaojue Hu
Therapists and religious professionals discuss ethical considerations in using psychedelics with vulnerable individuals, emphasizing the need for integrity and accountability in the psychedelic profession.
Cedar Barstow, Jennifer C Jones
Session explores health equity challenges and opportunities in mainstream psychedelic therapy, focusing on experiences of 3 women of color. Topics include overcoming inequity, cultural trauma, power dynamics, and ancestral healing.
Claudia Cuentas, Sara Reed, Deran Young
Psychedelic-assisted therapies for adolescents are discussed, including the use of ketamine for treatment-resistant depression and the need for further studies and careful consideration of risks. Traditional use of plant medicines
Corine de Boer, Rebecca Kronman, Glauber Assis